Search Results - "Locke, I"

Implementation of Royal College of Radiologists Consensus Statements and National Institute for Health and Care Excellence Guidance: Breast Radiotherapy Practice in the UK by Locke, I., Drinkwater, K.

“…Breast radiotherapy practice, driven by large randomised controls trials, is increasingly being risk adapted to the biology and stage of the cancer. The aim of…”
Get full text

Moving Forward Fast with FAST-Forward by Lewis, P., Brunt, A.M., Coles, C., Griffin, S., Locke, I., Roques, T.

Get full text

Locoregional control and toxicity following high-dose hypofractionated and accelerated palliative radiotherapy regimens in breast cancer by Webb, K., Gothard, L., Mohammed, K., Kirby, A.M., Locke, I., Somaiah, N.

“…For patients with locally advanced primary/recurrent breast cancer, radiotherapy is an effective treatment for locoregional control. 36 Gy in 6 Gy once-weekly…”
Get full text

The Radiotherapy Learning Healthcare System – Working Together to Improve the Quality of Radiotherapy Nationally by Burnett, A., Johnson, P., Locke, I., Illidge, T.

Get full text

Chondroprotection by urocortin involves blockade of the mechanosensitive ion channel Piezo1 by Lawrence, K. M., Jones, R. C., Jackson, T. R., Baylie, R. L., Abbott, B., Bruhn-Olszewska, B., Board, T. N., Locke, I. C., Richardson, S. M., Townsend, P. A.

“…Osteoarthritis (OA) is characterised by progressive destruction of articular cartilage and chondrocyte cell death. Here, we show the expression of the…”
Get full text

Cytotoxicity of clove (Syzygium aromaticum) oil and its major components to human skin cells by Prashar, A., Locke, I. C., Evans, C. S.

“…  The essential oil extracted from clove (Syzygium aromaticum) is used as a topical application to relieve pain and promote healing in herbal medicine and…”
Get full text

A Comparison of Isotoxic Dose-escalated Radiotherapy in Lung Cancer with Moderate Deep Inspiration Breath Hold, Mid-ventilation and Internal Target Volume Techniques by Bainbridge, H., Dunlop, A., McQuaid, D., Gulliford, S., Gunapala, R., Ahmed, M., Locke, I., Nill, S., Oelfke, U., McDonald, F.

“…With interest in normal tissue sparing and dose-escalated radiotherapy in the treatment of inoperable locally advanced non-small cell lung cancer, this study…”
Get full text

Novel Poly(3-hydroxyoctanoate)/Poly(3-hydroxybutyrate) blends for medical applications by Basnett, P., Ching, K.Y., Stolz, M., Knowles, J.C., Boccaccini, A.R., Smith, C., Locke, I.C., Keshavarz, T., Roy, I.

“…Novel Poly(3-hydroxybutyrate)/Poly(3-hydroxyoctanoate) blends were developed with varying amounts of Poly(3-hydroxyoctanoate), P(3HO) and…”
Get full text

Cytotoxicity of lavender oil and its major components to human skin cells by Prashar, A., Locke, I. C., Evans, C. S.

“…  Lavender (Lavandula angustifolia) oil, chiefly composed of linalyl acetate (51%) and linalool (35%), is considered to be one of the mildest of known plant…”
Get full text

127: 18-F fluorodeoxygenase (FDG) positron emission tomography (PET) scanning prior to radical lung radiotherapy. A retrospective audit of practice by Bainbridge, H, Locke, I, Ahmed, M, Oyen, W, McDonald, F

Get full text

Findings of the Royal College of Radiologists (UK) National Audit of Prostate Cancer Brachytherapy by Stewart, A.J, Drinkwater, K, Parkinson, N, Locke, I

Get full text

Phase I dose escalation of pembrolizumab given concurrently with palliative thoracic radiotherapy (RT) for NSCLC by Kumar, R., Walder, D.P., Pejanaute, A., Gunapala, R., Bhosle, J., Yousef, N., Popat, S., McDonald, F., Locke, I., Harrington, K., Tree, A., Lalondrelle, S., Huddart, R., O’Brien, M.E.R., Ahmed, M.

Get full text

OC-0167: Is radiographer led localisation for patients with metastatic spinal cord compression a feasible option? by Lacey, C, Ockwell, C, Locke, I, Thomas, K, Hendry, J, McNair, H

Get full text

EP-1053: Effect of fractionation schedule and treatment technique on cardiac doses from left breast radiotherapy by Bartlett, F, Lees, K, Locke, I, Kirby, A

Get full text

Palliative External Beam Radiotherapy for Painful Bone Metastases by Phillips, I, Locke, I, Kirby, A, Rahman, F

Get full text

Urocortin – From Parkinson's disease to the skeleton by Lawrence, K.M., Jackson, T.R., Jamieson, D., Stevens, A., Owens, G., Sayan, B.S., Locke, I.C., Townsend, P.A.

“…Urocortin (Ucn 1), a 40 amino acid long peptide related to corticotropin releasing factor (CRF) was discovered 19 years ago, based on its sequence homology to…”
Get full text

Urocortin protects chondrocytes from NO-induced apoptosis: a future therapy for osteoarthritis? by Intekhab-Alam, N Y, White, O B, Getting, S J, Petsa, A, Knight, R A, Chowdrey, H S, Townsend, P A, Lawrence, K M, Locke, I C

“…Osteoarthritis (OA) is characterized by a loss of joint mobility and pain resulting from progressive destruction and loss of articular cartilage secondary to…”
Get full text

Stereotactic body radiotherapy (SBRT) for metastatic breast cancer: an audit of the Royal Marsden experience by Henderson, D.R, Kirby, A, Locke, I, Ross, G, Tait, D, Khoo, V, van As, N

Get full text

A Royal College of Radiologists National Audit of Radiotherapy in the Treatment of Metastatic Spinal Cord Compression and Implications for the Development of Acute Oncology Services by McGivern, U.M, Drinkwater, K.J, Clarke, J.I.M, Locke, I

“…Abstract Aims To audit the current use of radiotherapy in UK cancer centres for the treatment of metastatic spinal cord compression against national standards…”
Get full text

PO-0782: Breast radiotherapy: invisible tattoos for external references (The BRITER study) by Landeg, S, Kirby, A.M, Lee, S, Bartlett, F, Donovan, E, Locke, I, Gothard, L, Boyle, S, Titmarsh, K, Griffin, C, McNair, H

Get full text